Strategic partnerships Leverage Patheon's role as a global CDMO within Thermo Fisher Scientific to position cross-company collaborations with biotech, pharma, and life sciences firms seeking integrated development, clinical, and manufacturing capabilities across diverse geographies.

Biologics and flexible manufacturing Patheon’s PharmaFlex platform for biologics and complex formulations signals a sales opportunity with companies advancing biologics, gene therapies, and cell-based products that require modular, scalable, and compliant manufacturing solutions.

Global footprint With over 60 locations and a broad global network, target mid-market and emerging biotech firms seeking international manufacturing and supply chain resilience, plus regional support for US, Europe, Asia, and Australia markets.

Recent collaborations Recent partnerships with Ethris, Cybin, RoosterBio and others imply a growing ecosystem for mRNA, gene therapy, and cellular/molecular therapeutics—propose targeted outreach to similar developers moving toward late-stage or commercial programs.

End-to-end capabilities Patheon offers API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials, logistics, and packaging—present opportunities to clients needing seamless transition from development to commercial manufacturing and packaging under one partner.